Cardiovascular Disease and Obesity

Obesity: Science to Practice

Volumn , Issue , 2009, Pages 287-320

  Iacobellis, Gianluca ^a   Sharma, Arya M ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cardiovascular disease and obesity; Catecholamine induced lipolysis; Congestive heart failure (CHF); Congestive heart failure and cardiac arrhythmias; Coronary heart disease (CHD); Hyperdynamic systolic function; Left ventricular hypertrophy (LVH); Sympathetic nervous system (SNS); Waist: hip ratio (WHR)

Indexed keywords

EID: 84889305054     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470712221.ch12     Document Type: Chapter

References (223)

1. Ajani, U.A., Lotufo, P.A. and Gaziano, J.M. (2004) Body mass index and mortality among US male physicians. Annals of Epidemiology, 14, 731-9.
2. Alpert, M.A., Terry, B.E., Cohen, M.V. et al. (2000) The electrocardiogram in morbid obesity. The American Journal of Cardiology, 85, 908-10.
3. American Diabetes Association (2003) Treatment of hypertension in adults with diabetes. Diabetes Care, 26, S80-2.
4. Andres, R. (1980) Effect of obesity on total mortality. International Journal of Obesity and Related Metabolic Disorders, 4, 381-6.
5. Anonymous (2008) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute, National High Blood Pressure. Education Program, NIH Publication No. 04-5230.
6. Arias, M.A., Alonso-Fernandez, A. and Garcia-Rio, F. (2006) Left ventricular diastolic abnormalities in obese subjects. Chest, 130, 1282-3.
7. Aucott, L., Poobalan, A., Smith, W.C. et al. (2005) Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review. Hypertension, 45, 1035-41.
8. Baik, I., Ascherio, A. and Rimm, E.B. (2000) Adiposity and mortality in men. American Journal of Epidemiology, 152, 264-71.
9. Baker, A.R., Silva, N.F., Quinn, D.W. et al. (2006) Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovascular Diabetology, 5, 1.
10. Barandier, C., Montani, J.P. and Yang, Z. (2005) Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity. American Journal of Physiology. Heart and Circulatory Physiology, 289, H1807-13.
11. Barouch, L.A., Berkowitz, D.E. and, Harrison, R.Wl. (2003) Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation, 108, 754-9.
12. Barton, M., Carmona, R., Ortmann, J. et al. (2003) Obesity-associated activation of angiotensin and endothelin in the cardiovascular system. The International Journal of Biochemistry & Cell Biology, 35, 826-37.
13. Batsis, J.A., Romero-Corral, A., Collazo-Clavell, M.L. et al. (2007) Effect of weight loss on predicted cardiovascular risk: change in cardiac risk after bariatric surgery. Obesity (Silver Spring), 15, 772-84.
14. Bettowski, J., Wójcicka, G. and Jamroz-Wisniewska, A. (2006) Role of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in the regulation of blood pressure by leptin in lean and obese rats. Life Sciences, 79, 63-71.
15. Black, H.R., Elliott, W.J., Grandits, G. et al. and CONVINCE Research Group (2003) Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. The Journal of the American Medical Association, 289, 2073-82.
16. Brandt, M., Harder, K., Walluscheck, K.P. et al. (2001) Severe obesity does not adversely affect perioperative mortality and morbidity in coronary artery bypass surgery. European Journal of Cardio-Thoracic Surgery, 19, 662-6.
17. Brochu, M., Tchernof, A. and Dionne, I.J. (2001) What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? The Journal of Clinical Endocrinology and Metabolism, 86, 1020-5.
18. Brown, D.W., Giles, W.H., Greenlund, K.J. et al. (2001) Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration: results from the Third National Health and Nutrition Examination Survey. Journal of Cardiovascular Risk, 8, 227-33.
19. Brown, M.J., Palmer, C.R., Castaigne, A. et al. (2000) Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet, 356, 366-72.
20. Buchwald, H. et al. (2004) Barametric surgery: a systematic review and meta-analysis. Journal of the American Medical Association, 292, 1724-37
21. Buse, J.B., Ginsberg, H.N., Bakris, G.L. et al. and American Heart Association, American Diabetes Association (2007) Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care, 30, 162-72 (simultaneously published in Circulation 115, 114-26).
22. Chadwick, J. and Mann, W.N. (1950) The Medical Works of Hippocrates. Aphorisms, sect. I144, Charles C Thomas Co, Springfield, IL, 154.
23. Chaldakov, G.N., Fiore, M., Stankulov, I.S. et al. (2004) Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? Progress in Brain Research, 146, 279-89.
24. Chiu, H.C., Kovacs, A., Ford, D.A. et al. (2001) A novel mouse model of lipotoxic cardiomyopathy. The Journal of Clinical Investigation, 107, 813-22.
25. Corradi, D., Maestri, R., Callegari, S. et al. (2004) The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovascular Pathology, 13, 313-6.
26. Correia, M.L., Morgan, D.A., Sivitz, W.I. et al. (2001) Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure. Hypertension, 37, 936-42.
27. Crisostomo, L.L., Araujo, L.M. and Camara, E. (1999) Comparison of left ventricular mass and function in obese versus nonobese women <40 years of age. The American Journal of Cardiology, 84, 1127-9.
28. Curtis, J.P., Selter, J.G., Wang, Y. et al. (2005) The obesity paradox: body mass index and outcomes in patients with heart failure. Archives of Internal Medicine, 165, 55-61.
29. Dagenais, G.R., Yi, Q., Mann, J.F. et al. (2005) Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. American Heart Journal, 159, 54-60.
30. Daniels, S.R., Kimball, T.R., Morrison, J.A. et al. (1995) Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents: statistical, biological, and clinical significance. Circulation, 92, 3249-54.
31. Date, H., Imamura, T., Ideguchi, T. et al. (2006) Adi-ponectin produced in coronary circulation regulates coronary flow reserve in nondiabetic patients with angiographically normal coronary arteries. Clinical Cardiology, 29, 211-4.
32. Davos, H., Doehner, W., Rauchhaus, M. et al. (2003) Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. Journal of Cardiac Failure, 9, 29-35.
33. DeFronzo, R.A., Cooke, C.R., Andres, R. et al. (1975) The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. The Journal of Clinical Investigation, 55, 845-55.
34. Delaughter, M.C., Taffet, G.E., Fiorotto, M.L. et al. (1999) Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice. The FASEB Journal, 13, 1923-9.
35. Della Mea, P., Lupia, M., Bandolin, V. et al. (2005) Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients. American Journal of Hypertension, 18, 30-5.
36. Derosa, G., Cicero, A.F., Murdolo, G. et al. (2005) Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients. Diabetes, Obesity & Metabolism, 7, 47-55.
37. Després, J.P., Golay, A., Sjöström, L. and Rimonabant in Obesity-Lipids Study Group (2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. The New England Journal of Medicine, 353, 2121-34.
38. Després, J.P. and Lemieux, I. (2006) Abdominal obesity and metabolic syndrome. Nature, 444, 881-7.
39. Diercks, D.B., Roe, M.T., Mulgund, J. et al. (2006) The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. American Heart Journal, 152, 140-8.
40. Domanski, M.J., Jablonski, K.A., Rice, M.M. et al. and PEACE Investigators (2006) Obesity and cardiovascular events in patients with established coronary disease. European Heart Journal, 27, 1416-22.
41. Dorbala, S., Crugnale, S., Yang, D. and Di Carli, M.F. (2006) Effect of body mass index on left ventricular cavity size and ejection fraction. The American Journal of Cardiology, 97, 725-9.
42. Douketis, J.D. and Sharma, A.M. (2005) Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction. Seminars in Veterinary Medicine, 5, 25-33.
43. Drøyvold, W.B., Midthjell, K., Nilsen, T.I. and Holmen, J. (2005) Change in body mass index and its impact on blood pressure: a prospective population study. International Journal of Obesity (London), 29, 650-5.
44. Dublin, S., French, B., Glazer, N.L. et al. (2006) Risk of new-onset atrial fibrillation in relation to body mass index. Archives of Internal Medicine, 166, 2322-8.
45. Dubrovska, G., Verlohren, S., Luft, F.C. and Gollasch, M. (2004) Mechanisms of ADRF release from rat aortic adventitial adipose tissue. The American Journal of Physiology, 286, H1107-13.
46. el-Gamal, A., Gallagher, D., Nawras, A. et al. (1995) Effects of obesity on QT, RR, and QTc intervals. The American Journal of Cardiology, 75, 956-9.
47. Engeli, S. (2005) Is there a pathophysiological role for perivascular adipocytes? American Journal of Physiology. Heart and Circulatory Physiology, 289, H1794-5.
48. Fonarow, G.C., Srikanthan, P., Costanzo, M.R. et al. (2007) ADHERE Scientific Advisory Committee and Investigators. An obesity paradox in acute heart failure: analysis of body mass index and in-hospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. American Heart Journal, 153, 74-81.
49. Fortuño, A., Rodriguez, A., Gomez-Ambrosi, J. et al. (2003) Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. Journal of Physiology and Biochemistry, 59, 51-60.
50. Frühbeck, G. (1999) Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes, 48, 903-8.
51. Frühbeck, G. (2004) The adipose tissue as a source of vasoactive factors. Current Medicinal Chemistry-Cardiovascular & Hematological Agents, 2, 197-208.
52. Galvan, A.Q., Galetta, F. and Natali, A. (2000) Insulin resistance and hyperinsulinemia: no independent relation to left ventricular mass in humans. Circulation, 102, 2233-8.
53. Galvez, B., de Castro, J., Herold, D. et al. (2006) Perivascular adipose tissue and mesenteric vascular function in spontaneously hypertensive rats. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1297-302.
54. Gami, A.S., Hodge, D.O., Herges, R.M. et al. (2007) Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. Journal of the American College of Cardiology, 49, 565-71.
55. Gao, Y.J., Takemori, K., Su, L.Y. et al. (2006) Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovascular Research, 71, 363-73.
56. Gao, Y.J., Zeng, Z.H., Teoh, K. et al. (2005) Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. The Journal of Thoracic and Cardiovascular Surgery, 130, 1130-6.
57. Gardin, J.M., McClelland, R., Kitzman, D. et al. (2001) M-mode echocardiographic predictors of six-to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). The American Journal of Cardiology, 87, 1051-7.
58. Girola, A., Enrini, R., Garbetta, F. et al. (2001) QT dispersion in uncomplicated human obesity. Obesity Research, 9, 71-7.
59. Gollasch, M. and Dubrovska, G. (2004) Paracrine role for periadventitial adipose tissue in the regulation of arterial tone. Trends in Pharmacological Sciences, 25, 647-53.
60. Gomez-Ambrosi, J., Salvador, J., Silva, C. et al. (2006) Increased cardiovascular risk markers in obesity are associated with body adiposity: role of leptin. Thrombosis and Haemostasis, 95, 991-6.
61. Gottdiener, J.S., Reda, D.J., Materson, B.J., Massie, B.M., Notargiacomo, A., Hamburger R.J., Williams, D.W. and Henderson, W.G. (1994) Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Journal of the American College of Cardiology 24, 1492-8.
62. Grandi, A.M., Zanzi, P. and Fachinetti, A. (1999) Insulin and diastolic dysfunction in lean and obese hypertensives. Hypertension, 34, 1208-14.
63. Greenwood, J.P., Scott, E.M., Stoker, J.B. and Mary, D.A. (2001) Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive. Journal of the American College of Cardiology, 15, 1711-7.
64. Gurm, H.S., Whitlow, P.L., Kip, K.E. and BARI Investigators (2002) The impact of body mass index on short-and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI). Journal of the American College of Cardiology, 39, 834-40.
65. Gustafsson, F., Kragelund, C.B., Torp-Pedersen, C. et al. and DIAMOND study group (2005) Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. European Heart Journal, 26, 58-64.
66. Habbu, A., Lakkis, N.M. and Dokainish, H. (2006) The obesity paradox: fact or fiction? The American Journal of Cardiology, 98, 944-8.
67. Henrichot, E., Juge-Aubry, C.E., Pernin, A. et al. (2005) Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 2594-9.
68. Hoit, B.D., Gilpin, E.A., Maisel, A.A. et al. (1987) Influence of obesity on morbidity and mortality after acute myocardial infarction. American Heart Journal, 114, 1334-41.
69. Hong, S.J., Park, C.G., Seo, H.S. et al. (2004) Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. Blood Pressure, 13, 236-42.
70. Horwich, T.B., Fonarow, G.C., Hamilton, M.A. et al. (2001) The relationship between obesity and mortality in patients with heart failure. Journal of the American College of Cardiology, 38, 789-95.
71. Hubert, H.B., Feinleib, M. and McNamara, P.M. (1983) Obesity as independent risk factor for cardiovascular disease: a 26-year follow-up of the participants in the Framingham Heart Study. Circulation, 67, 968-77.
72. Iacobellis, G. (2004) True uncomplicated obesity is not related to increased left ventricular mass and systolic dysfunction. Journal of the American College of Cardiology, 44, 2257.
73. Iacobellis, G. (2005a) Is obesity a risk factor for atrial fibrillation? Nature Clinical Practice Cardiovascular Medicine, 2, 134-5.
74. Iacobellis, G. (2005b) Imaging of visceral adipose tissue: an emerging diagnostic tool and therapeutic target. Current Drug Targets-Cardiovascular & Haematological Disorders, 5, 345-53.
75. Iacobellis, G. and Leonetti, F. (2005) Epicardial adipose tissue and insulin resistance in obese subjects. The Journal of Clinical Endocrinology and Metabolism, 90, 6300-2.
76. Iacobellis, G. and Sharma, A.M. (2006) Adiposity of the heart. Annals of Internal Medicine, 145, 554-5.
77. Iacobellis, G. and Sharma, A.M. (2007) Obesity and the heart: redefinition of the relationship. Obesity Reviews, 8, 35-9.
78. Iacobellis, G., Assael, F., Ribaudo, M.C. et al. (2003b) Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obesity Research, 11, 304-10.
79. Iacobellis, G., Corradi, D. and Sharma, A.M. (2005d) Epicardial adipose tissue: anatomical, biomolecular and clinical relation to the heart. Nature Clinical Practice Cardiovascular Medicine, 2, 536-43.
80. Iacobellis, G., Curione, M., Di Bona, S. et al. (2005c) Effect of acute hyperinsulinemia on ventricular repolarization in uncomplicated obesity. International Journal of Cardiology, 99, 161-3.
81. Iacobellis, G., Leonetti, F., Singh, N. and Sharma, A.M. (2007b) Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. International Journal of Cardiology, 115, 272-3.
82. Iacobellis, G., Moschetta, A., Buzzetti, R. et al. (2007c) Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin. Nutrition, Metabolism, and Cardiovascular Diseases 17, 442-7.
83. Iacobellis, G., Moschetta, A., Ribaudo, M.C. et al. (2005b) Normal serum alanine aminotransferase activity in uncomplicated obesity. World Journal of Gastroenterology, 11, 6018-21.
84. Iacobellis, G., Pellicelli, A.M., Grisorio, B. et al. (2007a) Relation of subepicardial adipose tissue with carotid intima media thickness in HIV-infected subjects. The American Journal of Cardiology, 99, 1470-2.
85. Iacobellis, G., Petrone, A., Leonetti, F. and Buzzetti, R. (2006a) Left ventricular mass and +276 G/G single nucleotide polymorphism of the adiponec-tin gene in uncomplicated obesity. Obesity (Silver Spring), 14, 368-72.
86. Iacobellis, G., Pistilli, D., Gucciardo, M. et al. (2005e) Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine, 29, 251-5.
87. Iacobellis, G., Ribaudo, M.C., Assael, F. et al. (2003c) Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. The Journal of Clinical Endocrinology and Metabolism, 88, 5163-8.
88. Iacobellis, G., Ribaudo, M.C., Leto, G. et al. (2002) Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obesity Research, 10, 767-73.
89. Iacobellis, G., Ribaudo, M.C., Zappaterreno, A. et al. (2003a) Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity. Obesity Research, 11, 518-24.
90. Iacobellis, G., Ribaudo, M.C., Zappaterreno, A. et al. (2004a) Adapted changes in left ventricular structure and function in severe uncomplicated obesity. Obesity Research, 12, 1616-21.
91. Iacobellis, G., Ribaudo, M.C., Zappaterreno, A. et al. (2004b) Relation between epicardial adipose tissue and left ventricular mass. The American Journal of Cardiology, 94, 1084-7.
92. Iacobellis, G., Ribaudo, M.C., Zappaterreno, A. and Leonetti, F. (2005a) Prevalence of uncomplicated obesity in a Italian obese population. Obesity Research, 13, 1116-22.
93. Ikonomidis, I., Mazarakis, A., Papadopoulos, C. et al. (2007) Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study. Journal of Hypertension, 25, 439-47.
94. Imamura, H., Izawa, A., Kai, R. et al. (2004) Trends over the last 20 years in the clinical background of young Japanese patients with coronary artery disease. Circulation Journal, 68, 186-91.
95. Jain, A., Avendano, G. and Dharamsey, S. (1996) Left ventricular diastolic function in hypertension and role of plasma glucose and insulin: comparison with diabetic heart. Circulation, 93, 1396-402.
96. James, W.P., Astrup, A., Finer, N. et al. (2000) Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet, 356 (9248), 2119-25.
97. Janssen, I., Katzmarzyk, P.T. and Ross, R. (2004) Waist circumference and not body mass index explains obesity-related health risk. The American Journal of Clinical Nutrition, 79, 379-84.
98. Janssen, I., Katzmarzyk, P.T. and Ross, R. (2005) Body mass index is inversely related to mortality in older people after adjustment for waist circumference. Journal of the American Geriatrics Society, 53, 2112-8.
99. Jeong, J.W., Jeong, M.H., Yun, K.H. et al. (2007) Echocardiographic epicardial fat thickness and coronary artery disease. Circulation Journal, 71, 536-9.
100. Jordan, J., Engeli, S., Redon, J. et al. and European Society of Hypertension Working Group on Obesity (2007) European Society of Hypertension Working Group on Obesity: background, aims and perspectives. Journal of Hypertension, 25, 897-900.
101. Kamide, K., Rakugi, H. and Higaki, J. (2002) The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. American Journal of Hypertension, 15, 66-71.
102. Kankaanpaa, M., Lehto, H.R., Parkka, J.P. et al. (2006) Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. The Journal of Clinical Endocrinology and Metabolism, 91, 4689-95.
103. Kannel, W.B., Plehn, J.F. and Cupples, L.A. (1988) Cardiac failure and sudden death in the Framingham Study. American Heart Journal, 115, 869-75.
104. Kaplan, R.C., Heckbert, S.R., Furberg, C.D. and Psaty, B.M. (2002) Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction. Journal of Clinical Epidemiology, 55, 654-64.
105. Karelis, A.D., Brochu, M. and Rabasa-Lhoret, R. (2004) Can we identify metabolically healthy but obese individuals (MHO)? Diabetes & Metabolism, 30, 569-72.
106. Karelis, A.D., St-Pierre, D.H., Conus, F. et al. (2004) Metabolic and body composition factors in subgroups of obesity: what do we know? The Journal of Clinical Endocrinology and Metabolism, 89, 2569-75.
107. Karelis, A.D., Faraj, M., Bastard, J.P. et al. (2005) The metabolically healthy, but obese individual presents a favorable inflammation profile. The Journal of Clinical Endocrinology and Metabolism 90, 4145-50.
108. Kim, J., Hammar, N., Jakobsson, K. et al. (2003) Obesity and the risk of early and late mortality after coronary artery bypass graft surgery. American Heart Journal, 146, 555-60.
109. Køber L., Torp-Pedersen C., Carlsen J.E et al. (1995) A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. The New England Journal of Medicine, 333, 1670-76.
110. Kragelund, C., Hassager, C., Hildebrandt, P. et al. and Trace study group (2005) Impact of obesity on long-term prognosis following acute myocardial infarction. International Journal of Cardiology, 98, 123-31.
111. Kremen, J., Dolinkova, M., Krajickova, J. et al. (2006) Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. The Journal of Clinical Endocrinology and Metabolism, 91, 4620-7.
112. Krishnan, R., Becker, R.J., Beighley, L.M. and Lopez-Candales, A. (2005) Impact of body mass index on markers of left ventricular thickness and mass calculation: results of a pilot analysis. Echocardiography, 22, 203-10.
113. Kuk, J.L., Janiszewski, P.M. and Ross, R. (2007) Body mass index and hip and thigh circumferences are negatively associated with visceral adipose tissue after control for waist circumference. The American Journal of Clinical Nutrition, 85, 1540-4.
114. Kuk, J.L., Katzmarzyk, P.T., Nichaman, M.Z. et al. (2006) Visceral fat is an independent predictor of all-cause mortality in men. Obesity Research, 14, 336-41.
115. Lalani, A.P., Kanna, B., John, J. et al. (2000) Abnormal signal-averaged electrocardiogram (SAECG) in obesity. Obesity Research, 8, 20-8.
116. Lembo, G., Vecchione, C., Fratta, L. et al. (2000) Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes, 49, 293-7.
117. Lewis, T.V., Dart, A.M. and Chin-Dusting, J.P. (1999) Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol. Journal of the American College of Cardiology, 33, 805-12.
118. Lin, S., Cheng, T.O., Liu, X. et al. (2006) Impact of dysglycemia, body mass index, and waist-to-hip ratio on the prevalence of systemic hypertension in a lean Chinese population. The American Journal of Cardiology, 97, 839-42.
119. Lissin, W., Gauri, A.J., Froelicher, V.F. et al. (2002) The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure. Journal of Cardiac Failure, 8, 206-15.
120. Löhn, M., Dubrovska, G., Lauterbach, B. et al. (2002) Periadventitial fat releases a vascular relaxing factor. The FASEB Journal, 16, 1057-63.
121. Lubrano, C., Cornoldi, A., Pili, M. et al. (2004) Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years' follow-up. International Journal of Obesity and Related Metabolic Disorders, 28, 1600-6.
122. Malavazos, A.E., Ermetici, F., Coman, C. et al. (2007) Influence of epicardial adipose tissue and adipocy-tokine levels on cardiac abnormalities in visceral obesity. International Journal of Cardiology 121, 132-4.
123. Malmqvist, K., Isaksson, H., Ostergren, J. and Kahan, T. (2001) Left ventricular mass is not related to insulin sensitivity in never-treated primary hypertension. Journal of Hypertension, 19, 311-7.
124. Malmqvist, K., Ohman, K.P., Lind, L. et al. (2002) Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin. Journal of Internal Medicine, 252, 430-9.
125. Marchesini, G., Melchionda, N., Apolone, G. and QUOVADIS. Study Group (2004) The metabolic syndrome in treatment-seeking obese persons. Metabolism: Clinical and Experimental, 53, 435-40.
126. Marchington, J.M., Mattacks, C.A. and Pond, C.M. (1989) Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comparative Biochemistry and Physiology B, 94, 225-32.
127. Marchington, J.M. and Pond, C.M. (1990) Site specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vivo. International Journal of Obesity, 14, 1013-22.
128. Marini, M.A., Succurro, E., Frontoni, S. et al. (2007) Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy non-obese women and obese insulin resistant women. Diabetes Care, 30, 2145-7.
129. Mazurek, T., Zhang, L., Zalewski, A. et al. (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation, 108, 2460-6.
130. McGavock, J.M., Victor, R.G., Unger, R.H. and Szczepaniak, L.S. (2006) Adiposity of the heart, revisited. Annals of Internal Medicine, 144, 517-24.
131. McMahon, F.G., Fujioka, K., Singh, B.N. et al. (2000) Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Archives of Internal Medicine, 160, 2185-91.
132. McMahon, F.G., Weinstein, S.P., Rowe, E. et al. and Sibutramine in Hypertensives Clinical Study Group (2002) Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors. Journal of Human Hypertension, 16, 5-11.
133. Meigs, J.B., Wilson, P.W., Fox, C.S. et al. (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. The Journal of Clinical Endocrinology and Metabolism, 91, 2906-12.
134. Mikhail, N., Golub, M.S. and Tuck, M.L. (1999) Obesity and hypertension. Progress in Cardiovascular Diseases, 42, 39-58.
135. Minutello, R.M., Chou, E.T., Hong, M.K. et al. (2004) Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry). The American Journal of Cardiology, 93, 1229-32.
136. Misra, A. and Vikram, N.K. (2003) Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition, 19, 457-66.
137. Mitsuhashi, H., Yatsuya, H., Tamakoshi, K. et al. (2007) Adiponectin level and left ventricular hypertrophy in Japanese men. Hypertension, 49, 1448-54.
138. Mombouli, J.V. and Vanhoutte, P.M. (1999) Endothelial dysfunction: from physiology to therapy. Journal of Molecular and Cellular Cardiology, 31, 61-74.
139. Momin, A.U., Melikian, N., Shah, A.M. et al. (2006) Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance. European Heart Journal, 27, 2294-9.
140. Montani, J.P., Carroll, J.F., Dwyer, T.M. et al. (2004) Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. International Journal of Obesity and Related Metabolic Disorders, 28 (Suppl 4), S58-65.
141. Mureddu, G.F., de Simone, G., Greco, R., Rosato, G.F. and Contaldo, F. (1996) Left ventricular filling pattern in uncomplicated obesity. The American Journal of Cardiology, 77, 509-14.
142. Mureddu, G.F., Greco, R. and Rosato, G.F. (1998) Relation of insulin resistance to left ventricular hypertrophy and diastolic dysfunction in obesity. International Journal of Obesity and Related Metabolic Disorders, 22, 363-8.
143. NIH (1998) Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: the evidence report. Obesity Research, 6, (Suppl 2), 51S-209S.
144. Noronha, B.T., Li, J.M., Wheatcroft, S.B. et al. (2005) Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes, 54, 1082-9.
145. Otto, M.E., Belohlavek, M., Khandheria, B. et al. (2004) Comparison of right and left ventricular function in obese and nonobese men. The American Journal of Cardiology, 93, 1569-72.
146. Otto, M.E., Belohlavek, M., Romero-Corral, A. et al. (2007) Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. The American Journal of Cardiology, 99, 1298-302.
147. Paolisso, G., Manzella, D., Montano, N. et al. (2000) Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. The Journal of Clinical Endocrinology and Metabolism, 85, 1810-4.
148. Paolisso, G., Tagliamonte, M.R. and Galderisi, M. (2001) Plasma leptin concentration, insulin sensitivity, and 24-hour ambulatory blood pressure and left ventricular geometry. American Journal of Hypertension, 14, 114-20.
149. Papaioannou, A., Michaloudis, D., Fraidakis, O. et al. (2003) Effects of weight loss on QT interval in morbidly obese patients. Obesity Surgery, 13, 869-73.
150. Pascual, M., Pascual, D.A. and Soria, F. (2003) Effects of isolated obesity on systolic and diastolic left ventricular function. Heart (British Cardiac Society), 89, 1152-6.
151. Pausova, Z. (2006) From big fat cells to high blood pressure: a pathway to obesity-associated hypertension. Current Opinion in Nephrology and Hypertension, 15, 173-8.
152. Perrio, M.J., Wilton, L.V. and Shakir, S.A. (2007) The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England. Obesity (Silver Spring), 15, 2712-22.
153. Peterson, L.R., Waggoner, A.D., Schechtman, K.B. et al. (2004) Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. Journal of the American College of Cardiology, 43, 1399-404.
154. Pickering, T.G., Hall, J.E., Appel, L.J. et al. (2005) Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation, 111, 697-716.
155. Pinkney, J.H. et al. (1994) Hypertension, 24, 362-4.
156. Pi-Sunyer, F.X., Aronne, L.J., Heshmati, H.M. et al. and RIO-North America Study Group (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. The Journal of the American Medical Association, 295, 761-75.
157. Pladevall, M., Williams, K. and Guyer, H. (2003) The association between leptin and left ventricular hypertrophy: a population-based cross-sectional study. Journal of Hypertension, 21, 1467-73.
158. Poirier, P., Giles, T.D., Bray, G.A. et al. and American Heart Association, Obesity Committee of the Council on Nutrition, Physical Activity, Metabolism (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation, 113, 898-918.
159. Pond, C.M. (2003) The contribution of wild animal biology to human physiology and medicine: adipose tissue associated with lymphoid and cardiac tissues. Ecoscience, 10, 1-9.
160. Pond, C.M. and Mattacks, C.A. (1991) The effect of noradrenalin and insulin on lipolysis in adipocytes isolated from nine different adipose depots of guinea-pigs. International Journal of Obesity, 15, 609-18.
161. Pond, C.M., Mattacks, C.A., Colby, R.H. and Tyler, N.J.C. (1993) The anatomy, chemical composition and maximum glycolytic capacity of adipose tissue in wild Svalbard reindeer in winter. Journal of Zoology, 229, 17-40.
162. Pontiroli, A.E., Pizzocri, P., Saibene, A. et al. (2004) Left ventricular hypertrophy and QT interval in obesity and in hypertension: effects of weight loss and of normalisation of blood pressure. International Journal of Obesity and Related Metabolic Disorders, 28, 1118-23.
163. Powell, B.D., Redfield, M.M., Bybee, K.A. et al. (2006) Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. The American Journal of Cardiology, 98, 116-20.
164. Rabkin, S.W., Mathewson, F.A. and Hsu, P.H. (1977) Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. The American Journal of Cardiology, 39, 452-8.
165. Rana, J.S., Mukamal, K.J., Morgan, J.P. et al. (2004) Obesity and the risk of death after acute myocardial infarction. American Heart Journal, 147, 841-6.
166. Rea, T.D., Heckbert, S.R., Kaplan, R.C. et al. (2001) Body mass index and the risk of recurrent coronary events following acute myocardial infarction. The American Journal of Cardiology, 88, 467-72.
167. Reeves, B.C., Ascione, R., Chamberlain, M.H. and Angelini, G.D. (2003) Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery. Journal of the American College of Cardiology, 42, 668-76.
168. Reiner, L., Mazzoleni, A. and Rodriguez, F.L. (1955) Statistical analysis of the epicardial fat weight in human hearts. AMA Archives of Pathology, 60, 369-73.
169. Reiner, L., Mazzoleni, A., Rodriguez, F.L. and Freudenthal, R.R. (1959) The weight of the human heart. I. Normal cases. AMA Archives of Pathology, 68, 58-73.
170. Reingold, J.S., McGavock, J.M., Kaka, S. et al. (2005) Determination of triglyceride in the human myocardium using magnetic resonance spectroscopy: reproducibility and sensitivity of the method. American Journal of Physiology. Endocrinology and Metabolism, 289, E935-9.
171. Remuzzi, G., Schieppati, A. and Ruggenenti, P. (2002) Clinical practice. Nephropathy in patients with type 2 diabetes. The New England Journal of Medicine, 346, 1145-51.
172. Rexrode, K.M., Carey, V.J., Hennekens, C.H. et al. (1998) Abdominal adiposity and coronary heart disease in women. The Journal of the American Medical Association, 280, 1843-8.
173. Romero-Corral, A., Montori, V.M., Somers, V.K. et al. (2006) Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet, 368, 666-78.
174. Sacks, H.S. and Fain, J.N. (2007) Human epicardial adipose tissue: a review. American Heart Journal, 153, 907-17.
175. Sader, S., Nian, M. and Liu, P. (2003) Leptin: a novel link between obesity, diabetes, cardiovascular risk, and ventricular hypertrophy. Circulation, 108, 644-6.
176. Sasson, Z., Rasooly, Y., Gupta, R. and Rasooly, I. (1996) Left atrial enlargement in healthy obese: prevalence and relation to left ventricular mass and diastolic function. The Canadian Journal of Cardiology, 12, 257-63.
177. Schächinger, V., Britten, M.B. and Zeiher, A.M. (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation, 101, 1899-906.
178. Schmieder, R.E. and Messerli, F.H. (1993) Does obesity influence early target organ damage in hypertensive patients? Circulation, 87, 1482-8.
179. Seyfeli, E., Duru, M., Kuvandik, G. et al. (2006) Effect of obesity on P-wave dispersion and QT dispersion in women. International Journal of Obesity (London), 30, 957-61.
180. Sharma, A.M. (2001) Sibutramine in overweight/obese hypertensive patients. International Journal of Obesity and Related Metabolic Disorders, 25 (Suppl 4), S20-3.
181. Sharma, A.M. (2004a) Mediastinal fat, insulin resistance, and hypertension. Hypertension, 44, 117-8.
182. Sharma, A.M. (2004b) Is there a rationale for angiotensin blockade in the management of obesity hypertension? Hypertension, 44, 12-9.
183. Sharma, A.M. and Chetty, V.T. (2005) Obesity, hypertension and insulin resistance. Acta Diabetologica, 42 (suppl 1), S3-8.
184. Sharma, A.M., Pischon, T., Engeli, S. and Scholze, J. (2001) Choice of drug treatment for obesity-related hypertension: where is the evidence? Journal of Hypertension, 19, 667-74.
185. Sharma, A.M., Janke, J., Gorzelniak, K. et al. (2002) Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertension, 40, 609-11.
186. Shechter, M., Beigel, R., Freimark, D. et al. (2006) Short-term sibutramine therapy is associated with weight loss and improved endothelial function in obese patients with coronary artery disease. The American Journal of Cardiology, 97, 1650-3.
187. Shimokawa, H. (1999) Primary endothelial dysfunction: atherosclerosis. Journal of Molecular and Cellular Cardiology, 31, 23-37.
188. Shin, M.J., Hyun, Y.J., Kim, O.Y. et al. (2006) Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. International Journal of Obesity (London), 30, 1529-34.
189. Shirani, J., Berezowski, K. and Roberts, W.C. (1995) Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. The American Journal of Cardiology, 76, 414-8.
190. Sims, A. (2001) Are there persons who are obese, but metabolically healthy? Metabolism: Clinical and Experimental, 50, 1499-504.
191. Sjöström, L., Lindroos, A.K., Peltonen, M. et al. (2004) Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. The New England Journal of Medicine, 351, 2683-93.
192. Smith, S.C., Jr, Blair, S.N., Bonow, R.O. et al. (2001) AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Journal of the American College of Cardiology, 38, 1581-3.
193. Smith, S.R. (2006) Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk. Obesity (Silver Spring), 14 (Suppl 3), 128S-34S.
194. Soltis, E.E. and Cassis, L.A. (1991) Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clinical and Experimental Hypertension, 275, 681-92.
195. Sowers, J.R. (2003) Obesity as a cardiovascular risk factor. The American Journal of Medicine, 8 (Suppl 8A), 37S-41S.
196. Steinberg, H.O., Chaker, H., Leaming, R. et al. (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. The Journal of Clinical Investigation, 97, 2601-2610.
197. Steinberg, H.O., Tarshoby, M., Monestel, R. et al. (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. The Journal of Clinical Investigation, 100, 1230-9.
198. Sundström, J., Lind, L. and Nyström, N. (2000) Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men. Circulation, 101, 2595-600.
199. Szczepaniak, L.S., Dobbins, R.L., Metzger, G.J. et al. (2003) Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magnetic Resonance in Medicine, 49, 417-23.
200. Tanaka, N., Ryoke, T. and Hongo, M. (1998) Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice. The American Journal of Physiology, 275, H393-9.
201. Tansey, D.K., Aly, Z. and Sheppard, M.N. (2005) Fat in the right ventricle of the normal heart. Histopatho-logy, 46, 98-104.
202. Torquati, A., Wright, K., Melvin, W. and Richards, W. (2007) Effect of gastric bypass operation on Framingham and actual risk of cardiovascular events in class II to III obesity. Journal of the American College of Surgeons, 204, 776-82.
203. Tritos, N.A., Manning, W.J. and Danias, P.G. (2004) Role of leptin in the development of cardiac hypertrophy in experimental animals and humans. Circulation, 109, 67.
204. Turnbull, F., Neal, B., Algert, C. et al. and Blood Pressure Lowering Trialists' Collaboration (2005) Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Archives of Internal Medicine, 165, 1410-9.
205. Valencia-Flores, M., Rebollar, V., Santiago, V. et al. (2004) Prevalence of pulmonary hypertension and its association with respiratory disturbances in obese patients living at moderately high altitude. International Journal of Obesity and Related Metabolic Disorders, 28, 1174-80.
206. Varughese, G.I. and Lip, G.Y. (2005) Anti hypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis. Journal of Human Hypertension, 19, 851-3.
207. Verlohren, S., Dubrovska, G., Tsang, S.-Y. et al. (2004) Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension, 44, 271-6.
208. Vogel, J.A., Franklin, B.A., Zalesin, K.C. et al. (2007) Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. The American Journal of Cardiology, 99, 222-6.
209. Wang, T.J., Parise, H., Levy, D. et al. (2004) Obesity and the risk of new-onset atrial fibrillation. The Journal of the American Medical Association, 292, 2471-7.
210. Wassertheil-Smoller, S., Fann, C., Allman, R.M. et al. (2000) Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group. Archives of Internal Medicine, 160, 494-500.
211. Watanabe, K., Sekiya, M., Tsuruoka, T. et al. (1999) Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension. Journal of Hypertension, 17, 1153-60.
212. Watts, G.F., O'Brien, S.F., Silvester, W. and Millar, J.A. (1996) Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. Clinical Science, 91, 567-73.
213. Weinberger, M.H. (1985) Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients. Journal of Cardiovascular Pharmacology, 7 (Suppl 1), S52-5.
214. Widlansky, M.E., Sesso, H.D., Rexrode, K.M. et al. (2004) Body Mass Index and total and cardiovascular mortality in men with a history of cardiovascular disease. Archives of Internal Medicine, 164, 2326-32.
215. Willens, H.J., Byers, P., Chirinos, J.A. et al. (2007) Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography. The American Journal of Cardiology, 99, 1242-5.
216. Wilson, P.W., D'Agostino, R.B., Sullivan, L. et al. (2002) Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Archives of Internal Medicine, 162, 1867-72.
217. Wirth, A., Scholze, J., Sharma, A.M. et al. (2006) Reduced left ventricular mass after treatment of obese patients with sibutramine: an echocardio-graphic multicentre study. Diabetes, Obesity & Metabolism, 8, 674-81.
218. Wong, C.H. and Marwick, T.H. (2007) Alterations in myocardial characteristics associated with obesity: detection, mechanisms, and implication. Trends in Cardiovascular Medicine, 17, 1-5.
219. Wong, C.Y., O'Moore-Sullivan, T., Leano, R. et al. (2004) Alterations of left ventricular myocardial characteristics associated with obesity. Circulation, 110, 3081-7.
220. Yusuf, S., Hawken, S., Ounpuu, S. et al. and Interheart Study Investigators (2005) Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet, 5, 1640-9.
221. Zacharias, A., Schwann, T.A., Riordan, C.J. et al. (2005) Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation, 112, 3247-55.
222. Zhang, X., Shu, X.O., Gao, Y.T. et al. (2004) Anthropometric predictors of coronary heart disease in Chinese women. International Journal of Obesity and Related Metabolic Disorders, 28, 734-40.
223. Zhou, Y.T., Grayburn, P., Karim, A. et al. (2000) Lipotoxic heart disease in obese rats: implications for human obesity. Proceedings of the National Academy of Sciences of the United States of America, 97, 1784-89.